Prognosis value of aberrant p16^<INK4a> gene methylation in colorectal cancer
p16^<INK4a>基因甲基化异常在结直肠癌中的预后价值
基本信息
- 批准号:18591494
- 负责人:
- 金额:$ 0.65万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Materials and MethodsThe subjects of our study comprised a series of 151 patients(mean age, 65.8 years ; range, 39-86) diagnosed and undergoing surgery for colorectal carcinoma. The median duration of follow-up was 79 months(range, 60-123). Slides stained with hematoxylin and eosin were examined, and pT, pN and pathological staging was completed according to the UICC/TNM classification. In addition, fresh tumor tissues and matched normal mucosa away from the tumor were currently obtained from 25 patients. Genomic DNA was extracted from formalin-fixed paraffin-embedded sections of 151 tumor and 10 normal tissues, with additional extraction from the frozen sections of 25 tumor tissues. Total RNA was extracted from the frozen sections of 25 tumor tissues and 4 matched normal mucosas. Bisulfite-modified DNA was amplified using specifically designed primers for the methylated and unmethylated p16 sequence. The real-time quantitative methylation specific PCR was performed, and the methylatio … More n index was calculated according to the equation : (concentration of methylated p16 sequence/concentrations of methylated plus unmethylated p16 sequence) X 100. Total RNA was employed to synthesize cDNA which was then used for real-time quantitative PCR. The primer pairs located in exons lα and 2 with flanking intron 1 of the p16 gene. Immunostaining was performed with monoclonal anti-p16(E6H4, Dako). In addition, image analysis was performed on p16 immunostained slides from randomly selected cases.Results Normal mucosa samples showed p16 methylation indices varying from 0 to 2%, and the indices of tumor samples represented 0 to 100%(median, 14.2% ; P=0.01) . Aberrant methylation of p16(methylation indices >2%) was detected in 100/151(66%) tumor samples. Loss of p16 expression(immunoreactivity <5%) was observed in 22/151(15%) cases. In image analyses, pl6-immunolabehng indices varied from 0 to 53% with no significant correlation to p16 methylation index. The expression level of p16 mRNA in normal tissues was consistently low whereas the value in tumor tissue was, in some cases, high level, which was statistically different(P=0.003). No significant correlation was observed between pl6 mRNA levels and methylation indiceswhereas p16 mRNA levels were positively correlated with p16-immunolabeling indices with statistically significant(P=0.043). Presence of p16 methylation was significantly associated with smaller tumor(P=0.048), but not with other clinicopathological features. In the Cox's regression model, present p16 methylation(P=0.007), high pT(P=0.007) and advanced tumor stage(P<0.001), proved to be independent predictors of short cancer-related survival. Cox's regression multivariate analysis also showed that p16 methylation(P<0.001), and advanced pN(P<0.001) and pT stages(P=0.014) predicted short recurrence-free survival. Less
材料和方法我们的研究对象包括 151 名被诊断为结直肠癌并接受手术的患者(平均年龄,65.8 岁;范围,39-86 岁),中位随访时间为 79 个月(范围,60-123 个月)。 )))检查用苏木精和伊红染色的载玻片,并根据UICC/TNM分类完成pT、pN和病理分期。目前,从 25 名患者的福尔马林固定石蜡包埋切片和 10 名正常组织中提取了基因组 DNA,并从 25 名肿瘤组织的冷冻切片中提取了总 RNA。使用针对甲基化和非甲基化 p16 专门设计的引物扩增从 25 个肿瘤组织和 4 个匹配的正常粘膜的冷冻切片中提取的 DNA。进行实时定量甲基化特异性PCR,并根据以下公式计算甲基化指数:(甲基化p16序列浓度/甲基化加非甲基化p16序列浓度)X 100。总RNA用于合成 cDNA,然后将其用于实时定量 PCR,引物对位于 p16 基因的外显子 1α 和 2 以及侧翼内含子 1 中。使用单克隆抗p16(E6H4,Dako)进行此外,对随机选择的病例的p16免疫染色切片进行图像分析。结果正常粘膜样本显示p16甲基化指数在0至2%之间变化,而肿瘤样本的指数则不同。代表 0 至 100%(中位数,14.2%;P=0.01) p16 的异常甲基化(甲基化指数)。在 100/151(66%)个肿瘤样本中检测到 p16 表达缺失(免疫反应性 <5%)。在图像分析中,p16 免疫标记指数从 0 变化。至 53%,与 p16 甲基化指数无显着相关性 正常组织中 p16 mRNA 的表达水平始终较低,而肿瘤组织中的值在某些情况下较高。 p16 mRNA水平与甲基化指数之间无显着相关性(P=0.003),而p16 mRNA水平与p16免疫标记指数呈正相关,且具有统计学意义(P=0.043)。与较小的肿瘤相关(P=0.048),但与其他临床病理特征无关。在 Cox 回归模型中,呈现 p16。甲基化(P=0.007)、高pT(P=0.007)和晚期肿瘤分期(P<0.001)被证明是癌症相关生存期短的独立预测因子,Cox回归多变量分析也显示p16甲基化(P<0.001)。 ,晚期 pN(P<0.001)和 pT 分期(P=0.014)预测较短的无复发生存期。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tumor budding at the invasive margin can predict prognosis in colorectal cancer
浸润边缘的肿瘤出芽可以预测结直肠癌的预后
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Ohta T.;Wu W;Fukuda M.;H.Kanazawa
- 通讯作者:H.Kanazawa
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANAZAWA Hideki其他文献
KANAZAWA Hideki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
多中心类别不平衡半监督医学影像分割及其在预后应用的方法研究
- 批准号:62306254
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于糖酵解代谢重编程机制的糖尿病肾病MRI预后评估研究
- 批准号:82371942
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于视网膜影像联合分子组学的视网膜动脉阻塞预后预测模型研究
- 批准号:82301205
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于系统动力学的儿童肿瘤幸存者心理健康对预后影响路径建模及应对策略研究
- 批准号:82303929
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
瓜氨酸通过肠道菌群调节肠粘膜免疫屏障改善脓毒症大鼠预后
- 批准号:82360371
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 0.65万 - 项目类别:
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:
10991546 - 财政年份:2024
- 资助金额:
$ 0.65万 - 项目类别:
Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
- 批准号:
10751263 - 财政年份:2024
- 资助金额:
$ 0.65万 - 项目类别:
進行がん患者の生存期間予測尺度の特定状況における診断精度の検証
晚期癌症患者生存预测量表特定情况下诊断准确性的验证
- 批准号:
23K09529 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Histopathology image analysis for prostate cancer prognosis after radical prostatectomy
前列腺癌根治术后预后的组织病理学图像分析
- 批准号:
478494 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Operating Grants